Pfizer actively strives to find innovative ways to minimize our impact on the environment during the manufacturing of pharmaceuticals and is continuously greening" the process. In particular, we leverage our Green Chemistry programs to advance scientific innovation to help develop processes that are more sustainable, environmentally sound and cost-effective. Whereas the impact can easily be quantified with tangible metrics during the manufacturing phase of a pharmaceutical, there exists the opportunity for significant contributions to be made within medicinal chemistry during the discovery phase. However, thinking “Green” is often perceived to be contrary to the mindset of a traditional medicinal chemist. This talk will focus on the challenges faced in changing this culture, and how enabling technologies such as flow chemistry, <i>in situ</i> reaction monitoring and reaction screening can help to overcome these. In addition, case studies will be provided detailing the significant benefits these changes have made within our Oncology Drug Discovery programs.<br/>

Green chemistry at Pfizer: Applications to the oncology portfolio

Macromolecular Chemistry: The Second Century

[Author Benefits](https://scimeetings.acs.org/?utm_source=pubs_content_marketing&utm_medium=website&utm_campaign=0320_MCF_NPI_Launch_Spring_Homepage&ref=pubs_content_marketing)

[How to use SciMeetings](https://storage.googleapis.com/dl.morressier.com/acs/SciMeetings-ACSSpring2020-HowToGuide_M3020-Final.pdf)

[Frequently Asked Questions](https://storage.googleapis.com/dl.morressier.com/acs/SciMtng_ACSNMSp2020_FAQ_M3120_Final.pdf)

ACS Spring 2020 National Meeting & Expo

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.